Bridgeway Capital Management, LLC Ionis Pharmaceuticals Inc Transaction History

Bridgeway Capital Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$47.45 - $62.95 $1.71 Million - $2.27 Million	-36,000 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$46.85 - $61.05 $9,370 - $12,210	-200 Reduced 0.55%	36,000 $2.12 Million
Q3 2019 Nov 14, 2019	BUY	$59.06 - $72.15 $2.14 Million - $2.61 Million	36,200 New	36,200 $2.17 Million

394

125M

2.25M

510K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.8B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.